Assessing the Accuracy of the NeuroBooster Array for GBA1 Variant Detection

NeuroBooster Array genotyping detects GBA1 variants in 3,744 individuals with 85.5% accuracy, identifying 520/608 carriers versus reference sequencing.

• Why it matters: GBA1 variants are key Parkinson’s disease risk factors, yet reliable detection is difficult, creating a need to benchmark genotyping performance.
• What they did: The study compared NeuroBooster Array (NBA) calls to reference sequencing across 3,744 individuals, then tallied missed calls and false positives.
• The result: NBA missed 89 calls (73 with no matching probe, 16 with missing calls) and produced 25 false positives, supporting use for case-control analysis rather than standalone clinical decisions.

AI summary of the abstract · may contain errors · not medical advice · read the paper.